GCTK GlucoTrack, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 5, 2026 10-K/10-Q Ağu 14, 2026
$1,16
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,1452 haftanın en düşüğü
$136,2952 haftanın en yükseği
Piyasa Değeri (MRQ)
$7M
P/E
0.0
Hisse Başına Kâr
$31.22
rozetleriniz
52 Haftlık Aralık
$1–$136
Analist Derecelendirmesi
·
Fiyat Hedefi
·
P/E
0.0
ROE
-399.4%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
GCTK Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.16
Piyasa Değeri (MRQ)
$7M
P/E
0.0
Hisse Başına Kâr
$31.22
ROE
-399.4%
52 Haftlık Aralık
$1–$136
GCTK Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 31 Ağustos 2026 | 1-for-15 | Ters |
| 16 Haziran 2025 | 1-for-60 | Ters |
| 04 Şubat 2025 | 1-for-20 | Ters |
| 20 Mayıs 2024 | 1-for-5 | Ters |
| 13 Ağustos 2021 | 1-for-13 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2016-12-31 → 2019-12-31
Hisse Başına Kâr$31.222016-12-31 → 2025-12-31
Serbest Nakit Akışı$-15M2016-12-31 → 2025-12-31
Net kar marjı·2016-12-31 → 2019-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | GCTK | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | 0.05Y ort. ≈25089.9 | ≈25089.9 | · | · | |
| P/S (F/S) | 9.05Y ort. ≈351254.6 | ≈351254.6 | · | · | |
| F/D (MRQ) | -4.25Y ort. ≈29215.4 | ≈29215.4 | · | · | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | -0.15Y ort. ≈-11728.5 | ≈-11728.5 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -0.15Y ort. ≈-10050.8 | ≈-10050.8 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.45Y ort. ≈47971.8 | ≈47971.8 | · | · | |
| PEG Ratio (PEG Oranı) | ≈0.0 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | GCTK | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -281.6%5Y ort. ≈-248.5% | ≈-248.5% | · | · | |
| ROE | -399.4%5Y ort. ≈-133.5% | ≈-133.5% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | GCTK | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 0.55Y ort. ≈2.9 | ≈2.9 | · | · | |
| Quick Ratio (Cari Oran) | 1.55Y ort. ≈2.8 | ≈2.8 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | GCTK | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| EPS YoY (EPS YB) | -99.2%5Y ort. ≈4709.6% | ≈4709.6% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 375.7%5Y ort. ≈1083.0% | ≈1083.0% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 177.4% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $208.0K | $43.5K | $589.5K | $611.7K | $143.2K | $59.8K | |
| R&D Expense | $10M | $9M | $5M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | |
| SG&A Expense | $6M | $5M | $2M | $2M | $2M | $415.0K | $2M | $2M | $6M | $1M | $1M | $230.8K | |
| Operating Expenses | $16M | $15M | $7M | $4M | $4M | $3M | $4M | $7M | $11M | $6M | $5M | $4M | |
| Operating Income | $-16M | $-15M | $-7M | $-4M | $-4M | $-3M | $4M | $-7M | $11M | $-6M | $-5M | $-4M | |
| Interest Expense | · | $44.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $26.0K | $14.0K | · | $-14.0K | $-53.0K | $338.0K | $10.5K | $176.8K | $247.0K | · | · | · | |
| Pretax Income | · | · | · | · | · | $-3M | $-4M | $-7M | $-10M | $-5M | $-6M | $3M | |
| Net Income | $-19M | $-23M | $-7M | $-4M | $-4M | $-3M | $4M | $-7M | $10M | $-5M | $-6M | $3M | |
| EPS (Basic) | $31.22 | $4106.00 | $34.18 | $0.29 | $0.26 | $-0.02 | $-0.02 | $-4.74 | $-1.87 | $-1.08 | $-1.15 | $0.37 | |
| EPS (Diluted) | $31.22 | $4106.00 | $34.18 | $0.29 | $0.26 | $0.19 | $-0.02 | $-4.74 | $-1.87 | $-1.08 | $-1.15 | $0.37 | |
| Shares (Basic) | 621,094 | 5,503 | 207,603 | 15,474,600 | 15,450,824 | 196,029,360 | 154,929,064 | 8,396,847 | 6,285,324 | 5,788,842 | 5,476,870 | 5,304,500 | |
| Shares (Diluted) | 621,094 | 5,503 | 207,603 | 15,474,600 | · | 196,029,360 | 154,929,064 | 8,396,847 | 6,285,324 | 5,788,842 | 5,476,870 | 5,349,242 | |
| EBITDA | $-16M | $-15M | $-7M | $-4M | · | · | $-4M | $7M | $-11M | $-6M | · | $-4M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $6M | $4M | $2M | $6M | $10M | $419.0K | $97.1K | $53.8K | $148.8K | $608.7K | $6M | |
| Receivables | · | · | · | · | · | $66.0K | $70.0K | $22.8K | $121.8K | $92.1K | $18.4K | $23.2K | |
| Inventory | · | · | · | · | · | $284.0K | $184.0K | $171.0K | $957.3K | $1M | $816.2K | $83.7K | |
| Prepaid Expense | · | · | · | · | · | · | $23.3K | $13.6K | $30.3K | $90.6K | $57.2K | $46.1K | |
| Other Current Assets | $284.0K | $151.0K | $376.0K | $67.0K | $43.0K | $56.0K | $45.0K | $23.3K | $94.1K | $357.0K | $268.8K | $113.8K | |
| Current Assets | $8M | $6M | $5M | $2M | $6M | $10M | $718.0K | $314.1K | $1M | $2M | $2M | $6M | |
| PP&E (Net) | $138.0K | $95.0K | $27.0K | $40.0K | $69.0K | $149.0K | $134.0K | $149.8K | $216.7K | $240.5K | $220.5K | $122.5K | |
| PP&E (Gross) | · | · | · | $294.0K | $489.0K | $774.0K | $669.0K | $594.8K | $637.4K | $556.6K | $473.5K | $331.5K | |
| Accum. Depreciation | · | · | · | $254.0K | $420.0K | $625.0K | $535.0K | $445.0K | $420.6K | $316.2K | $253.0K | $209.0K | |
| Total Assets | $8M | $6M | $5M | $2M | $6M | $11M | $1M | $688.2K | $2M | $2M | $2M | $6M | |
| Accounts Payable | $1M | $992.0K | $839.0K | $672.0K | $631.0K | $869.0K | $2M | $2M | $2M | $2M | $1M | $104.7K | |
| Accrued Liabilities | · | · | · | $325.0K | $131.0K | $148.0K | $401.0K | $917.4K | $929.2K | $349.8K | $187.5K | $235.9K | |
| Current Liabilities | $5M | $1M | $2M | $1M | $883.0K | $1M | $2M | $3M | $4M | $2M | $2M | $1M | |
| Capital Leases | $5.0K | $33.0K | · | · | $17.0K | $82.0K | $45.0K | · | · | · | · | · | |
| Other Non-current Liabilities | $231.0K | $203.0K | $196.0K | $195.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $5M | $19M | $2M | $1M | $1M | $2M | $3M | $4M | $5M | $3M | $2M | $3M | |
| Common Stock | $1.0K | $1.0K | · | $15.0K | $15.0K | $15.0K | $162.0K | $141.6K | $6.8K | $6.0K | $5.7K | $5.3K | |
| Retained Earnings | $-152M | $-132M | $-110M | $-102M | $-97M | $-93M | $-91M | $-87M | $-47M | $-36M | $-29M | $-23M | |
| AOCI | $41.0K | $-8.0K | $16.0K | $17.0K | $-6.0K | $15.0K | $124.0K | $164.2K | $110.7K | $62.6K | $90.2K | $66.7K | |
| Stockholders' Equity | $3M | $-13M | $3M | $1M | $5M | $9M | $-1M | $-3M | $-17M | $-11M | $-7M | $-5M | |
| Liabilities + Equity | $8M | $6M | $5M | $2M | $6M | $11M | $1M | $688.2K | $2M | $2M | $2M | $6M | |
| Shares Outstanding | 910,688 | 13,409 | 208,914 | 15,500,730 | 15,470,402 | 15,444,697 | 161,858,436 | 141,634,700 | 6,821,792 | 6,026,527 | 5,690,097 | 5,323,058 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $32.0K | $32.0K | · | · | · | · | · | · | |
| Stock-based Comp | $211.0K | $173.0K | $281.0K | $439.0K | $223.0K | $22.0K | $356.0K | $705.2K | $3M | $70.2K | $18.0K | $50.4K | |
| Operating Cash Flow | $-15M | $-12M | $-7M | $-4M | $-4M | $-4M | $-4M | $-5M | $-6M | $-5M | $-5M | $-3M | |
| CapEx | $96.0K | $104.0K | · | $1.0K | $5.0K | $53.0K | $23.0K | $5.4K | $19.5K | $76.5K | $143.7K | $63.5K | |
| Investing Cash Flow | $-96.0K | $-104.0K | · | $1.0K | $-1.0K | $-53.0K | $-23.0K | $-5.4K | $-19.5K | $-76.5K | $-203.2K | · | |
| Stock Issued | · | · | · | · | · | $13M | $4M | $3M | $205.4K | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | $4M | $3M | $205.4K | · | · | · | |
| Financing Cash Flow | $17M | $14M | $9M | · | · | $13M | $4M | $5M | $6M | $5M | $-460.9K | · | |
| Net Change in Cash | $2M | $1M | $2M | $-4M | $-4M | $9M | $326.0K | $56.3K | $-91.2K | $-459.9K | $-5M | $3M | |
| Free Cash Flow | $-15M | $-13M | · | $-4M | · | · | $-4M | $-5M | $-6M | $-5M | · | $-3M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | -1679.2% | 15035.4% | -1794.2% | -924.6% | · | -6034.9% | |
| Net Margin | · | · | · | · | · | · | -1684.3% | 15442.0% | -1752.2% | -884.4% | · | 4986.1% | |
| Pretax Margin | · | · | · | · | · | · | -1684.3% | -15442.0% | -1752.2% | -884.4% | · | 4986.1% | |
| EBITDA Margin | · | · | · | · | · | · | -1679.2% | 15035.4% | -1794.2% | -924.6% | · | -6034.9% | |
| ROA | -281.6% | -417.0% | -193.3% | -101.9% | · | · | -356.8% | 569.8% | -500.2% | -235.5% | · | 65.5% | |
| ROE | -399.4% | 265.5% | -162.1% | -237.8% | · | · | 309.2% | -71.2% | 75.0% | 60.4% | · | -37.5% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 4.5 | 3.2 | 2.3 | · | · | 0.3 | 0.1 | 0.3 | 0.9 | · | 6.0 | |
| Quick Ratio | 1.5 | 4.4 | 3.0 | 2.3 | · | · | 0.2 | 0.0 | 0.0 | 0.1 | · | 5.9 | |
| Interest Coverage | · | -330.6 | · | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.2 | 0.0 | 0.3 | 0.3 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 4.5 | 0.6 | 5.5 | 11.1 | · | 5.1 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.11 | $-16.42 | $0.15 | $0.08 | · | · | $-0.01 | $-0.02 | $-2.43 | $-1.82 | · | $-0.91 | |
| Revenue / Share | · | · | · | · | · | · | $0.00 | $0.01 | $0.09 | $0.11 | · | $0.01 | |
| Cash Flow / Share | $-24.54 | $-37.83 | $-0.32 | · | · | · | $-0.03 | $-0.58 | $-0.94 | $-0.92 | · | $-0.63 | |
| Cash / Share | $8.11 | $7.10 | $0.21 | $0.15 | · | · | $0.00 | $0.00 | $0.01 | $0.02 | · | $1.09 | |
| EPS (TTM) | $31.22 | $4106.00 | $34.18 | $0.29 | $0.26 | $0.19 | $-0.02 | $-4.74 | $-1.87 | $-1.08 | $-1.15 | $0.37 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS YoY | -99.2% | 11912.9% | 11686.2% | 11.5% | 36.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 375.7% | 2408.9% | 464.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 177.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117.0K | $117.0K | $117.0K | $117.0K | $117.0K | $117.0K | $208.0K | $43.5K | $589.5K | $611.7K | $143.2K | $59.8K | |
| Net Income TTM | $-19M | $-23M | $-7M | $-4M | $-4M | $-3M | $4M | $-7M | $10M | $-5M | $-6M | $3M | |
| Market Cap | $4M | $354M | $32.84B | $131.14B | · | · | $7.62T | $5.52T | $1.06T | $1.18T | · | $2.49T | |
| P/E | 0.1 | 0.1 | 46.0 | 29172.4 | 96230.8 | 145736.8 | -2340000.0 | -8227.8 | -83422.5 | -180555.6 | -237391.3 | 1264864.9 | |
| P/S | 30.1 | 3029.3 | 280791.8 | 1121167.0 | · | · | 36637846.9 | 127017873.9 | 1805374.3 | 1921193.2 | · | 41676145.7 | |
| P/B | 1.2 | -27.3 | 10272.9 | 106614.8 | · | · | -5398598.3 | -1922441.6 | -64205.4 | -107327.3 | · | -515539.5 | |
| P / Tangible Book | 1.2 | · | 10272.9 | 106614.8 | 74998.3 | 618974.4 | · | · | · | · | · | · | |
| P / Cash Flow | -0.2 | -28.4 | -5008.0 | -35166.6 | · | · | -1954476.0 | -1129076.2 | -180522.1 | -221236.9 | · | -741063.3 | |
| P / FCF | -0.2 | -28.1 | · | -35157.2 | · | · | -1942800.6 | -1127838.0 | -179928.0 | -218097.7 | · | -727334.0 | |
| Earnings Yield | 806.7% | 917.3% | 2.2% | 0.00% | 0.00% | 0.00% | 0.00% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $4M | $2M | $2M | $2M | $627.0K | $642.0K | $604.0K | $434.0K | |
| SG&A Expense | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $802.0K | $733.0K | $553.0K | $531.0K | $552.0K | $642.0K | $683.0K | $495.0K | |
| Operating Expenses | $3M | $4M | $3M | $4M | $5M | $3M | $4M | $3M | $4M | $3M | $2M | $2M | $1M | $1M | $1M | $929.0K | |
| Operating Income | $-3M | $-4M | $-3M | $-4M | $-5M | $-3M | $-4M | $-3M | $-4M | $-3M | $-2M | $-2M | $-1M | $-1M | $-1M | $-929.0K | |
| Interest Expense | · | · | · | · | · | · | · | $5.0K | · | · | · | · | · | · | · | · | |
| Other Non-op | $-414.0K | $-132.0K | $-18.0K | $136.0K | $-96.0K | $4.0K | $2.0K | $12.0K | · | · | · | · | · | · | $-13.0K | $-1.0K | |
| Net Income | $-4M | $-4M | $-4M | $-4M | $-5M | $-7M | $-10M | $-5M | $-4M | $-3M | $-2M | $-2M | $-1M | $-1M | $-1M | $-928.0K | |
| EPS (Basic) | $0.76 | $2.65 | $17.63 | $4.64 | $9.62 | $40.14 | $2041.73 | $1092.00 | $984.00 | $-11.73 | $34.48 | $-0.49 | $0.27 | $-0.08 | $0.49 | $-0.06 | |
| EPS (Diluted) | $0.76 | $2.65 | $17.63 | $4.64 | $9.62 | $40.14 | $2041.73 | $1092.00 | $984.00 | $-11.73 | $34.48 | $-0.49 | $0.27 | $-0.08 | $0.49 | $-0.06 | |
| Shares (Basic) | 5,009,085 | 1,638,128 | · | 899,410 | 494,504 | 169,345 | · | 4,663 | 4,564 | 249,598 | · | 4,593,733 | 4,312,294 | 15,503,632 | · | 15,473,521 | |
| Shares (Diluted) | 5,009,085 | 1,638,128 | · | 899,410 | 494,504 | 169,345 | · | 4,663 | 4,564 | 249,598 | · | 4,593,733 | 4,312,294 | 15,503,632 | · | 15,473,521 | |
| EBITDA | $-3M | $-4M | · | $-4M | $-5M | $-3M | · | $-3M | $-4M | $-3M | · | $-2M | $-1M | $-1M | · | $-929.0K |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $4M | $7M | $8M | $10M | $9M | $6M | $346.0K | $159.0K | $1M | $4M | $7M | $9M | $1M | $2M | $3M | |
| Other Current Assets | $257.0K | $285.0K | $284.0K | $237.0K | $522.0K | $355.0K | $151.0K | $296.0K | $283.0K | $440.0K | $376.0K | $281.0K | $171.0K | $203.0K | $67.0K | $187.0K | |
| Current Assets | $1M | $4M | $8M | $8M | $10M | $9M | $6M | $642.0K | $442.0K | $2M | $5M | $7M | $9M | $1M | $2M | $3M | |
| PP&E (Net) | $95.0K | $116.0K | $138.0K | $144.0K | $87.0K | $94.0K | $95.0K | $109.0K | $86.0K | $82.0K | $27.0K | $17.0K | $27.0K | $35.0K | $40.0K | $44.0K | |
| Total Assets | $1M | $4M | $8M | $8M | $10M | $10M | $6M | $826.0K | $608.0K | $2M | $5M | $7M | $9M | $1M | $2M | $4M | |
| Accounts Payable | $1M | $1M | $1M | $2M | $3M | $2M | $992.0K | $2M | $3M | $1M | $839.0K | $1M | $832.0K | $652.0K | $672.0K | $713.0K | |
| Short-term Debt | · | · | · | · | · | · | · | · | $12.0K | · | · | · | · | · | · | · | |
| Current Liabilities | $3M | $5M | $5M | $5M | $3M | $2M | $1M | $5M | $4M | $1M | $2M | $1M | $1M | $1M | $1M | $965.0K | |
| Capital Leases | · | · | $5.0K | $12.0K | $19.0K | $26.0K | $33.0K | $40.0K | $46.0K | $53.0K | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $231.0K | · | · | · | $203.0K | $197.0K | $191.0K | $195.0K | $196.0K | $184.0K | $189.0K | $193.0K | $195.0K | · | |
| Total Liabilities | $3M | $5M | $5M | $6M | $3M | $2M | $19M | $5M | $4M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | |
| Total Debt | · | · | · | · | · | · | · | · | $12.0K | · | · | · | · | · | · | · | |
| Common Stock | $6.0K | $3.0K | $1.0K | $1.0K | $1.0K | $26.0K | $1.0K | $6.0K | $5.0K | $27.0K | · | $20.0K | $20.0K | $15.0K | $15.0K | $15.0K | |
| Retained Earnings | $-160M | $-156M | $-152M | $-148M | $-144M | $-139M | $-132M | $-122M | $-117M | $-113M | $-110M | $-107M | $-105M | $-103M | $-102M | $-101M | |
| AOCI | $52.0K | $44.0K | $41.0K | $42.0K | $41.0K | $28.0K | $-8.0K | $5.0K | $22.0K | $22.0K | $16.0K | $34.0K | $28.0K | $22.0K | $17.0K | $30.0K | |
| Stockholders' Equity | $-2M | $-851.0K | $3M | $3M | $7M | $7M | $-13M | $-4M | $-3M | $376.0K | $3M | $6M | $8M | $11.0K | $1M | $2M | |
| Liabilities + Equity | $1M | $4M | $8M | $8M | $10M | $10M | $6M | $826.0K | $608.0K | $2M | $5M | $7M | $9M | $1M | $2M | $4M | |
| Shares Outstanding | 6,259,279 | 2,524,279 | 910,688 | 899,410 | 899,410 | 25,585,853 | 13,409 | 5,772,026 | 5,478,436 | 26,756,369 | 208,914 | 20,892,193 | 20,892,193 | 15,503,632 | 15,500,730 | 15,476,665 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $9.0K | $11.0K | $8.0K | · | $10.0K | $8.0K | $4.0K | · | · | · | $4.0K | · | · | |
| Stock-based Comp | $59.0K | $61.0K | $90.0K | $41.0K | $40.0K | $40.0K | $-66.0K | $11.0K | $206.0K | $22.0K | $21.0K | $31.0K | $172.0K | $57.0K | $165.0K | $76.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-41.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-4M | $-4M | $-4M | $-5M | $-4M | $-3M | $-3M | $-4M | $-2M | $-3M | $-2M | $-2M | $-954.0K | $-1M | $-940.0K | $-608.0K | |
| CapEx | · | · | $20.0K | $67.0K | $0 | $9.0K | $0 | $33.0K | $12.0K | $59.0K | · | · | · | · | $-3.0K | $0 | |
| Investing Cash Flow | · | · | $-20.0K | $-67.0K | $0 | $-9.0K | $0 | $-33.0K | $-12.0K | $-59.0K | · | · | · | · | $5.0K | $0 | |
| Financing Cash Flow | $803.0K | $591.0K | $3M | $3M | $4M | $6M | $9M | $4M | · | · | $0 | $0 | · | · | · | · | |
| Net Change in Cash | $-3M | $-3M | $-486.0K | $-2M | $445.0K | $3M | $5M | $188.0K | $-1M | $-3M | $-2M | $-2M | $8M | $-1M | $-949.0K | $-618.0K | |
| Free Cash Flow | · | · | · | · | · | $-3M | · | · | · | $-3M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -65.2% | -62.1% | · | -91.5% | -87.9% | -116.6% | · | -126.8% | -93.6% | -174.4% | · | -41.5% | -17.7% | -38.9% | · | -16.7% | |
| ROE | -148.4% | -135.3% | · | 656.3% | -264.9% | -179.0% | · | -662.8% | -201.6% | -1512.7% | · | -56.2% | -21.5% | -60.6% | · | -21.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 0.8 | · | 1.5 | 3.3 | 4.8 | · | 0.1 | 0.1 | 1.3 | · | 4.9 | 8.5 | 1.2 | · | 3.6 | |
| Quick Ratio | 0.4 | 0.8 | · | 1.5 | 3.1 | 4.7 | · | 0.1 | 0.0 | 1.0 | · | 4.7 | 8.4 | 1.0 | · | 3.4 | |
| Debt / Equity | · | · | · | · | · | · | · | · | -0.0 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | -650.2 | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.28 | $-0.34 | · | $3.06 | $7.65 | $0.28 | · | $-0.70 | $-0.60 | $0.01 | · | $0.27 | $0.37 | $0.00 | · | $0.15 | |
| Cash Flow / Share | · | $-2.47 | · | · | · | $-0.29 | · | · | · | $-0.12 | · | · | · | · | · | · | |
| Cash / Share | $0.18 | $1.56 | · | $8.75 | $10.62 | $0.36 | · | $0.06 | $0.03 | $0.06 | · | $0.33 | $0.42 | $0.06 | · | $0.21 | |
| EPS (TTM) | $25.68 | $34.54 | · | $2096.13 | $3183.49 | $4157.87 | · | $2098.75 | $1006.26 | $22.53 | · | $0.19 | $0.62 | $0.28 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $74.2K | $74.2K | · | $74.2K | $74.2K | $74.2K | · | $74.2K | $74.2K | $74.2K | · | $74.2K | $74.2K | $74.2K | · | $74.2K | |
| Net Income TTM | $-16M | $-17M | · | $-26M | $-27M | $-27M | · | $-15M | $-12M | $-9M | · | $-6M | $-5M | $-5M | · | $-5M | |
| Market Cap | $2M | $2M | · | $6M | $5M | $269M | · | $16.69B | $13.21B | $53.14B | · | $32.97B | $43.25B | $31.63B | · | $184.79B | |
| Enterprise Value | · | · | · | · | · | · | · | · | $13.21B | · | · | · | · | · | · | · | |
| P/E | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 1.4 | 2.4 | 88.1 | · | 8305.3 | 3338.7 | 7285.7 | · | · | |
| P/S | 26.9 | 22.1 | · | 79.9 | 72.7 | 3621.1 | · | 224996.3 | 178107.7 | 716234.4 | · | 444365.0 | 582912.2 | 426297.1 | · | 2490752.0 | |
| P/B | -1.1 | -1.9 | · | 2.2 | 0.8 | 37.0 | · | -4150.3 | -4017.6 | 141324.9 | · | 5932.7 | 5585.3 | 2875219.0 | · | 78467.7 | |
| P / Tangible Book | · | · | · | 2.2 | 0.8 | 37.0 | · | · | · | 141324.9 | · | 5932.7 | 5585.3 | 2875219.0 | · | 78467.7 | |
| P / Cash Flow | · | -0.4 | · | · | · | -91.4 | · | · | · | -18061.9 | · | · | · | -24087.9 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 178105.7 | · | · | · | · | · | · | · | |
| Earnings Yield | 8050.2% | 5313.9% | · | 31807.7% | 53058.2% | 39598.8% | · | 72.6% | 41.7% | 1.1% | · | 0.01% | 0.03% | 0.01% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-19M | $-23M | $-7M | $-4M | $-4M |
| Seyreltilmiş Hisse Başı Kâr | $31.22 | $4106.00 | $34.18 | $0.29 | $0.26 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 1.6 | 4.5 | 3.2 | 2.3 | · |
| Cari Oran | 1.5 | 4.4 | 3.0 | 2.3 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-15M | $-13M | · | $-4M | · |
Kurumsal Sahipler (13F) 19 dosya · $116K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
19
Tutulan Değer
$116K
Yeni pozisyonlar
9
Çıkan pozisyonlar
3
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 9 (+5 önceki Ç'ye göre) | 3 (+2 önceki Ç'ye göre) | 2 (-1 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | +428K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $40.978 | 128.459 | 35,29% | Hisse senetleri |
| CITADEL ADVISORS LLC | $25.370 | 79.530 | 21,85% | Hisse senetleri |
| Ikarian Capital, LLC | $14.621 | 45.830 | 12,59% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $10.911 | 34.207 | 9,40% | Hisse senetleri |
| GRANITE ISLANDS PRIVATE WEALTH, LLC | $5.008 | 15.700 | 4,31% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $4.314 | 13.525 | 3,71% | Hisse senetleri |
| UBS Group AG | $4.257 | 13.343 | 3,67% | Hisse senetleri |
| CITIGROUP INC | $4.106 | 12.872 | 3,54% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.364 | 10.546 | 2,90% | Hisse senetleri |
| ALERUS FINANCIAL NA | $1.276 | 4.000 | 1,10% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $1.098 | 3.442 | 0,95% | Hisse senetleri |
| BARCLAYS PLC | $402 | 1.259 | 0,35% | Hisse senetleri |
| PlanVest Financial, Inc | $319 | 1.000 | 0,27% | Hisse senetleri |
| HRT FINANCIAL LP | $65 | 205.442 | 0,06% | Hisse senetleri |
| Tradewinds Capital Management, LLC | $16 | 50 | 0,01% | Hisse senetleri |
| NFSG Corp | $11 | 34 | 0,01% | Hisse senetleri |
| Virtu Financial LLC | $6 | 18.726 | 0,01% | Hisse senetleri |
| SBI Securities Co., Ltd. | $3 | 9 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $0 | 2 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Tax Identification Number JOHN A BALLANTYNE REV TRUST 08/01/2017, Tax Identification Number JOHN A BALLANTYNE | 25 Şubat 2020 | · | İlk başvuru | · | SEC |
| Vayikra Capital, LLC, Philip Darivoff ×2 başvurular | 15 Mart 2017 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 20 içeriden öğrenenler · 6 yöneticiler · 14 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Paul Goode | Chief Executive Officer | 25 Mart 2025 J | 339 | 0 | 0 | $0 |
| John A Graham | Chief Executive Officer | 20 Mart 2017 A | · | 0 | 0 | $0 |
| Avner Gal | Chairman and CEO | 11 Mart 2015 J | 273.989 | 0 | 0 | $0 |
| Eran Hertz | Chief Financial Officer | 30 Eylül 2014 A | · | 0 | 0 | $0 |
| Angela Strand Boydston | Interim Chief Strategy Officer | 01 Haziran 2017 A | 4.445 | 0 | 0 | $0 |
| David Malka | Vice President of Operations | 13 Nisan 2017 A | 123.695 | 0 | 0 | $0 |
| Erin Catherine Carter | Yönetim kurulu üyesi | 03 Ekim 2025 A | 2.148 | 0 | 0 | $0 |
| Allen Danzig | Yönetim kurulu üyesi | 26 Mart 2025 A | 1.922 | 0 | 0 | $0 |
| Robert Fischell | Yönetim kurulu üyesi | 26 Mart 2025 A | 2.045 | 0 | 0 | $0 |
| John Ballantyne | Yönetim kurulu üyesi | 12 Mart 2025 X | 4.126 | 0 | 0 | $0 |
| Drew Sycoff | Yönetim kurulu üyesi | 01 Temmuz 2024 P | 2.951.258 | 0 | 0 | $0 |
| Michael Hauck | Yönetim kurulu üyesi | 01 Haziran 2017 A | · | 0 | 0 | $0 |
| Revan Schwartz | Yönetim kurulu üyesi | 01 Haziran 2017 A | · | 0 | 0 | $0 |
| Leslie Seff | Yönetim kurulu üyesi | 01 Haziran 2017 A | 3.334 | 0 | 0 | $0 |
| Philip Darivoff | Yönetim kurulu üyesi | 08 Mart 2017 P | · | 0 | 0 | $0 |
| Zvi Cohen | Yönetim kurulu üyesi | 11 Mart 2015 J | 241.625 | 0 | 0 | $0 |
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 | 10% sahip | 12 Mart 2025 X | 2.743.591 | 0 | 0 | $0 |
| Luis Malave | · | 03 Ekim 2025 A | 4.058 | 0 | 0 | $0 |
| Andrew K Balo | · | 03 Ekim 2025 A | 4.692 | 0 | 0 | $0 |
| David Podwalski | · | 26 Haziran 2017 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026